Healthcare Industry News: collagen scaffold
News Release - October 28, 2008
Pegasus Biologics Names Rob Cripe Vice President of Marketing and Product Development
IRVINE, Calif.--(HSMN NewsFeed)--Pegasus Biologics, Inc. a privately held developer of collagen scaffolds for soft tissue repair and wound care management, announced today that it has named Rob Cripe Vice President of Marketing and Product Development. Cripe brings to Pegasus more than 18 years of experience in the orthopedic medical device field where his responsibilities have included marketing, product development and clinical development on a worldwide scale.Prior to his arrival at Pegasus, Cripe served as Vice President of Smith & Nephew’s Global Hip Franchise, where he was responsible for marketing and development for the company’s worldwide hip portfolio. Prior to joining Smith & Nephew, Cripe was VP of Marketing and Development for Kinetikos Medical, Inc (KMI), specializing in orthopedic hardware for extremities.
“We’re proud to have added Rob to our senior executive team at Pegasus Biologics,” said Michael D. Will, Pegasus Biologics’ President and CEO. “He brings us nearly two decades of US and international orthopedic experience as well as terrific surgeon relationships. We’re confident that Rob’s broad experience in orthopedics, biologics, extremities, sports medicine and total joints make him a valuable addition to the Pegasus management team.”
Cripe started his career with Biomet, functioning in various sales, marketing and field management roles. This led to an opportunity with Interpore Cross International, where he was responsible for the company’s biologics product offering in a marketing role, and ultimately served as the Vice President of Marketing and Development for the company.
Pegasus Biologics, Inc. has the exclusive rights to unique patented technologies related to the stabilization and sterilization of biologic tissue and collagen scaffolds. The Company currently manufactures and markets the OrthADAPT® Bioimplant for surgical implantation to support the repair and reinforcement of soft tissue in orthopedic procedures and the Unite® Biomatrix collagen dressing for advanced wound management.
About Pegasus Biologics, Inc.
Pegasus Biologics, Inc. (Irvine, CA) is a privately held company focused on the research, development, and commercialization of next generation biologics utilizing the Company’s unique and patented technologies. Additional information on the Company can be found at www.pegasusbio.com
Source: Pegasus Biologics
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
